The Chinese government has approved two more common vaccines for COVID-19 developed in their country.
China’s National Drug Supervisory Service announced through its internet homepage today (25th) that it has conditionally approved the general use of the vaccine applied by the Chinese pharmaceutical group Sinopharm’s Wuhan Bio Products Research Institute and Cancino Bio.
Earlier, Chinese authorities approved the general vaccination of the corona vaccine developed by Sinoparm and Sinobac.
Synoparm’s approved vaccine is different from the vaccine released by the company earlier.
As a result, the total number of vaccines in China that can be vaccinated has increased to four.
[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]
– .
Related posts:
Collect celebrity moments, entertainers, celebrate Christmas. Happy New Year 2022
BBVA's tensions with the CNMV, the ECB and the National Court over the Villarejo case
iPhone 14 Series Will Have a New Bangs Look, Cooler than iPhone 13?
China's Economic Recovery Hindered by Dictatorship and Wrong Decision-Making, Foreign Media Say
